Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun 18:11:708943.
doi: 10.3389/fonc.2021.708943. eCollection 2021.

Editorial: Novel Combination Therapies for the Treatment of Solid Cancers

Nehad M Ayoub  1
Affiliations
Editorial

Editorial: Novel Combination Therapies for the Treatment of Solid Cancers

Nehad M Ayoub. Front Oncol. .
No abstract available

Keywords: combination; efflux transporters; repositioning; resistance; synergy.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Combination Therapies for the Treatment of Solid Cancers

References

    1. Frei E, 3rd, Karon M, Levin RH, Freireich EJ, Taylor RJ, Hananian J, et al. . The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children With Acute Leukemia. Blood (1965) 26(5):642–56. 10.1182/blood.V26.5.642.642 - DOI - PubMed
    1. Ismail M, Khan S, Khan F, Noor S, Sajid H, Yar S, et al. . Prevalence and Significance of Potential Drug-Drug Interactions Among Cancer Patients Receiving Chemotherapy. BMC Cancer (2020) 20(1):335. 10.1186/s12885-020-06855-9 - DOI - PMC - PubMed
    1. Bayat Mokhtari R, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, et al. . Combination Therapy in Combating Cancer. Oncotarget (2017) 8(23):38022–43. 10.18632/oncotarget.16723 - DOI - PMC - PubMed
    1. Falzone L, Salomone S, Libra M. Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Front Pharmacol (2018) 9:1300. 10.3389/fphar.2018.01300 - DOI - PMC - PubMed
    1. Kwak EL, Clark JW, Chabner B. Targeted Agents: The Rules of Combination. Clin Cancer Res (2007) 13(18 Pt 1):5232–7. 10.1158/1078-0432.CCR-07-1385 - DOI - PubMed

Publication types

LinkOut - more resources